Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.80)
# 488
Out of 5,133 analysts
140
Total ratings
49.4%
Success rate
25.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMA ImageneBio | Reiterated: Buy | $28 | $3.47 | +706.92% | 3 | Nov 13, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $25.66 | $9.50 | +170.07% | 17 | Nov 13, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $90 → $75 | $28.10 | +166.90% | 15 | Nov 6, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $25 | $6.84 | +265.50% | 24 | Nov 5, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $1.71 | +309.36% | 20 | Oct 19, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $185 | $37.27 | +396.38% | 20 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $55 | $16.14 | +240.77% | 7 | Oct 1, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $8 | $4.27 | +87.35% | 19 | Oct 1, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $15.73 | +8.07% | 3 | Feb 27, 2026 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.03 | n/a | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.70 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27.00 → $35.00 | $25.54 | n/a | 3 | Apr 3, 2023 |
ImageneBio
Nov 13, 2026
Reiterated: Buy
Price Target: $28
Current: $3.47
Upside: +706.92%
Satellos Bioscience Inc.
Nov 13, 2026
Reiterated: Buy
Price Target: $25.66
Current: $9.50
Upside: +170.07%
Vera Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $90 → $75
Current: $28.10
Upside: +166.90%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $25
Current: $6.84
Upside: +265.50%
Adagene
Oct 19, 2026
Reiterated: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
Nektar Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $185
Current: $37.27
Upside: +396.38%
Jade Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $55
Current: $16.14
Upside: +240.77%
Prime Medicine
Oct 1, 2026
Reiterated: Buy
Price Target: $8
Current: $4.27
Upside: +87.35%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $15.73
Upside: +8.07%
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.03
Upside: n/a
Jun 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $24.70
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $27.00 → $35.00
Current: $25.54
Upside: n/a